共 560 条
[1]
Cesario A(2014)P4 medicine needs P4 education Curr Pharm Des 20 6071-6072
[2]
Auffray C(2014)A systems medicine clinical platform for understanding and managing non-communicable diseases Curr Pharm Des 20 5945-5956
[3]
Russo P(2014)Survival for haematological malignancies in Europe between 1997 and 2008 by region and age: results of EUROCARE-5, a population-based study Lancet Oncol 15 931-942
[4]
Hood L(2013)Mechanisms of programmed DNA lesions and genomic instability in the immune system Cell 152 417-429
[5]
Cesario A(2014)Racial differences in three major NHL subtypes: descriptive epidemiology Cancer Epidemiol 39 8-13
[6]
Auffray C(2011)The 2008 WHO classification of lymphoid neoplasms and beyond: evolving concepts and practical applications Blood 117 5019-5032
[7]
Agusti A(2008)Six versus eight cycles of bi-weekly CHOP-14 with or without rituximab in elderly patients with aggressive CD20+ B-cell lymphomas: a randomised controlled trial (RICOVER-60) Lancet Oncol 9 105-116
[8]
Apolone G(2006)CHOP-like chemotherapy plus rituximab versus CHOP-like chemotherapy alone in young patients with good-prognosis diffuse large-B-cell lymphoma: a randomised controlled trial by the MabThera International Trial (MInT) Group Lancet Oncol 7 379-391
[9]
Balling R(2015)B-cell receptor signaling in diffuse large B-cell lymphoma Semin Hematol 52 77-85
[10]
Barbanti P(2008)Molecular subtypes of diffuse large B-cell lymphoma arise by distinct genetic pathways Proc Natl Acad Sci USA 105 13520-13525